Aucta Pharmaceuticals, Inc
2 clinical trials · Sponsor
◉ Watch Aucta Pharmaceuticals, Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects (NCT03239353) | Aucta Pharmaceuticals, Inc | 2017-10-20 |
Track Aucta Pharmaceuticals, Inc automatically
Every clearance here is in the API, with alerts when new ones post.